Thirty states already allow patients safe and legal access to medical cannabis. Data from these states demonstrates that the enactment of laws protecting patients is associated with lower rates of opioid abuse and mortality, and does not negatively impact workplace safety, teen use, or motor vehicle safety.
Clinical trials acknowledge that marijuana possesses therapeutic efficacy. A recent review of several of these clinical trials assessing cannabis, published in The Open Neurology Journal concludes, “Based on evidence currently available the Schedule I classification (for cannabis) is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking.”
Cannabis is helping countless patients throughout the country in states that allow legal access. To encourage a better legislative understanding this issue, from a medical and political perspective, please support HCR 149.